{"version":"1.0","provider_name":"Allphase Pharma Consulting, LLC","provider_url":"https:\/\/allphasepharma.com\/dir","author_name":"Harald","author_url":"https:\/\/allphasepharma.com\/dir\/author\/haraldeva\/","title":"Trial Pains Secondary to Placebo Effect? - Allphase Pharma Consulting, LLC","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"lStGZmuXlT\"><a href=\"https:\/\/allphasepharma.com\/dir\/2014\/06\/09\/259\/trial-pains-secondary-to-placebo-effect\/\">Trial Pains Secondary to Placebo Effect?<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/allphasepharma.com\/dir\/2014\/06\/09\/259\/trial-pains-secondary-to-placebo-effect\/embed\/#?secret=lStGZmuXlT\" width=\"600\" height=\"338\" title=\"&#8220;Trial Pains Secondary to Placebo Effect?&#8221; &#8212; Allphase Pharma Consulting, LLC\" data-secret=\"lStGZmuXlT\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script>\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n\/\/# sourceURL=https:\/\/allphasepharma.com\/dir\/wp-includes\/js\/wp-embed.min.js\n<\/script>\n","thumbnail_url":"https:\/\/allphasepharma.com\/dir\/wp-content\/uploads\/2014\/06\/Rodin.jpe","thumbnail_width":220,"thumbnail_height":229,"description":"An interesting report has just been published showing that Naloxegol is beneficial in OIC [i].\u00a0 Naloxegol is a \u00b5 opioid receptor (MOR) antagonist which \u2013 by virtue of pegylation \u2013 acts peripherally and not centrally.\u00a0 Hence, the analgesic effects of opioid therapy are unaffected while the very bothersome side effect Continue reading  &rarr;"}